Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor. GLP-1 medications were originally intended to treat type 2 diabetes, but ...

LONDON: Doctors worldwide should diagnose obesity differently, relying on broader criteria and taking into account when the condition causes ill-health, according to a new framework drawn up by ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles, cannot seem to shed the pounds hurting their health. “They ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...

The just-published findings reveal what regulates a gene that’s pivotal to our food intake - and also our risk of obesity.

The FDA has designed five different types of labels, each presenting the same information but with different specifications based on the size of the packaging.

Under recommendations released Tuesday night, obesity would no longer be defined solely by BMI, a calculation of height and ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...